Kras Co-mutations lead to resistance to mutant TP53 targeted therapy in mouse models of spontaneous non-small cell lung cancer.

被引：0
|
作者：
Costa, David T. [1 ]
Grier, Shaylyn [1 ]
Perez, Melanie [1 ]
Gao, Li [1 ]
Villalona-Calero, Miguel A. [2 ]
Duan, Wenrui [1 ]
机构：
[1] Florida Int Univ, Miami, FL USA
[2] City Hope Natl Med Ctr, Med Ctr, Duarte, CA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6184
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Poor prognosis of concurrent KRAS and TP53 mutations in patients with resected non-squamous non-small cell lung cancer (NSCLC)
    Pecuchet, N.
    Laurent-Puig, P.
    Pallier, K.
    Le Pimpec-Barthes, F.
    Riquet, M.
    Cazes, A.
    Fabre, E.
    Blons, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S813 - S813
  • [22] VEGF-A Expression Correlates with TP53 Mutations in Non-Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy
    Schwaederle, Maria
    Lazar, Vladimir
    Validire, Pierre
    Hansson, Johan
    Lacroix, Ludovic
    Soria, Jean-Charles
    Pawitan, Yudi
    Kurzrock, Razelle
    [J]. CANCER RESEARCH, 2015, 75 (07) : 1187 - 1190
  • [23] Impact of TP53 mutations on efficacy of PD-1 targeted immunotherapy in non-small cell lung cancer (NSCLC).
    Carlisle, Jennifer Wilkinson
    Nhu Thi Nho
    Kim, Chaejin
    Chen, Zhengjia
    Li, Shiyong
    Hill, Charles
    Ramalingam, Suresh S.
    Sica, Gabriel
    Owonikoko, Taofeek Kunle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] CTNNB1 Mutations and Co-Mutations in Non-Small Cell Lung Cancer
    Romero, Andres Mindiola
    Tafe, Laura
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1805 - 1806
  • [25] Prognostic value of KRAS/TP53/PIK3CA in non-small cell lung cancer
    Zhao, Jiayi
    Han, Yiping
    Li, Jiamei
    Chai, Rong
    Bai, Chong
    [J]. ONCOLOGY LETTERS, 2019, 17 (03) : 3233 - 3240
  • [26] Polymorphisms in Apoptosis-Related Genes and TP53 Mutations in Non-Small Cell Lung Cancer
    Bae, Eun Young
    Lee, Eun Jin
    Kang, Hyo-Gyoung
    Lee, Shin Yup
    Jin, Gwang
    Lee, Won Kee
    Choi, Jin Eun
    Jeon, Hyo-Sung
    Lim, Jeong Ok
    Lee, Eung Bae
    Park, Jae Yong
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (11) : 1527 - 1530
  • [27] Association of TP53 Mutations with Response to Anlotinib Treatment in Advanced Non-Small Cell Lung Cancer
    Fang, Shencun
    Cheng, Wanwan
    Zhang, Meiling
    Yang, Rusong
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 6645 - 6650
  • [28] CTNNB1 Mutations and Co-Mutations in Non-Small Cell Lung Cancer
    Romero, Andres Mindiola
    Tafe, Laura
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1805 - 1806
  • [29] Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non-small-cell Lung Cancer
    Tomasini, Pascale
    Mascaux, Celine
    Jao, Kevin
    Labbe, Catherine
    Kamel-Reid, Suzanne
    Stockley, Tracy
    Hwang, David M.
    Leighl, Natasha B.
    Liu, Geoffrey
    Bradbury, Penelope A.
    Pintilie, Melania
    Tsao, Ming-Sound
    Shepherd, Frances A.
    [J]. CLINICAL LUNG CANCER, 2019, 20 (03) : E338 - E345
  • [30] TP53 mutation, allelism and survival in non-small cell lung cancer
    Nelson, HH
    Wilkojmen, M
    Marsit, CJ
    Kelsey, KT
    [J]. CARCINOGENESIS, 2005, 26 (10) : 1770 - 1773
12345